Multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution.
David DierksMiguel Angel Garcia-CamposAnna UzonyiModi SafraSarit EdelheitAlice RossiTheodora SideriRadhika A VarierAlexander BrandisYonatan StelzerFolkert van WervenRuth Scherz-ShouvalSchraga SchwartzPublished in: Nature methods (2021)
N6-methyladenosine (m6A) is the most prevalent modification of messenger RNA in mammals. To interrogate its functions and dynamics, there is a critical need to quantify m6A at three levels: site, gene and sample. Current approaches address these needs in a limited manner. Here we develop m6A-seq2, relying on multiplexed m6A-immunoprecipitation of barcoded and pooled samples. m6A-seq2 allows a big increase in throughput while reducing technical variability, requirements of input material and cost. m6A-seq2 is furthermore uniquely capable of providing sample-level relative quantitations of m6A, serving as an orthogonal alternative to mass spectrometry-based approaches. Finally, we develop a computational approach for gene-level quantitation of m6A. We demonstrate that using this metric, roughly 30% of the variability in RNA half life in mouse embryonic stem cells can be explained, establishing m6A as a main driver of RNA stability. m6A-seq2 thus provides an experimental and analytic framework for dissecting m6A-mediated regulation at three different levels.
Keyphrases
- genome wide
- single cell
- rna seq
- mass spectrometry
- dna methylation
- copy number
- embryonic stem cells
- genome wide identification
- liquid chromatography
- high performance liquid chromatography
- gene expression
- high resolution
- ms ms
- machine learning
- transcription factor
- nucleic acid
- clinical trial
- big data
- randomized controlled trial
- gas chromatography
- study protocol
- tandem mass spectrometry